Cancer · 1975 · 272 citations · 21 references
MedicineOncologyPharmacologyChemotherapyRadiation ProtectionRadiobiologyBiological Effects Of RadiationRadiation BiologyRadiation PhysiologyRadiation TherapyRadiation ToxicityRadiation-induced Cell DeathCellular Radiation DamageRadiation DamageRadiation Damage EffectsRadiation Effects On The Gastrointestinal TractRadiation-induced Esophageal InjuryRadioprotection MechanismsRadioprotective EffectsTissue Radiation Injury
The study evaluated how various chemotherapeutic agents affect radiation-induced injury in mouse normal tissues (intestine, esophagus, lung) using quantitative endpoints. Actinomycin D increased injury in all tissues, BCNU had no effect, adriamycin markedly worsened intestinal damage, bleomycin raised esophageal injury, cyclophosphamide increased lung injury, vincristine and hydroxyurea had minimal or no effect, and only prednisolone provided significant radioprotection when administered at irradiation or anticipated pulmonary death.
The effects of several cancer chemotherapeutic agents on radiation damage to normal intestine, esophagus, and lung tissue were evaluated in LAF1 mice using quantitive endpoints. In all tissues tested, actinomycin D increased injury and BCNU did not. In the intestine, adriamycin enhanced radiation damage more than any other agent. Bleomycin increased damage in the esophagus but not in the lung or intestine. Cyclophosphamide increased injury only in the lung, where vincristine caused minimal injury, and hydroxyurea, none. Only prednisolone caused significant radioprotection when given at the time of irradiation or at the time of expected death from pulmonary injury.
21
Emil J. Freireich, E. A. Gehan, David P. Rall et al. · PubMed · 1966 · 1.4K citations
Pharmacy, Oncology, Toxicology +14
Radiation pneumonitis: A new approach to the derivation of time-dose factors
William M. Wara, Theodore L. Phillips, Lawrence W. Margolis et al. · Cancer · 1973 · 233 citations · Full text